The use of BCS and biowaivers to accelerate drug development

The ongoing COVID-19 pandemic is extensively impacting clinical trials irrespective of indication and not just in terms of patient enrollment and care but will also impact data collection and analysis in the months to come.

Absorption Systems is a company whose mission is to develop innovative research tools that can be used to accurately predict human outcomes.

There’s never been a time when this has been more critical. We care about this impact on your therapeutic programs and we can help.

Whether you are developing a new chemical entity or reformulating an existing drug product or focused on generic product approval, we have a path forward to enable progress.


Knowing the BCS class of your compound can help:

  • Predict in vivo absorption
  • Predict disposition
  • Potential for food effects
  • Guide your formulation strategy
  • Potentially waive clinical studies